pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    OR-449
    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Orphagen Pharmaceuticals Inc
  • Preclinical
    OR-812
    Male Contraception Orphagen Pharmaceuticals Inc
  • Preclinical
    ORG-101
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… Orgenesis Inc
  • Phase 2
← prev
page 118 of 231
next →
131
Pain89
Neurology1
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
$ORKA Oruka Therapeutics, Inc.
  • Phase 2
    ORTHO-R
    Unspecified Musculoskeletal Disorders ChitogenX Inc
  • Phase 2
    ORX-142
    Sleep Disorders$CNTA Centessa Pharmaceuticals plc
  • Preclinical
    OS-151
    Tuberculosis OncoSTING LLC
  • Phase 3
    OSE-2101
    Tedopi
    Non-Small Cell Lung Cancer OSE Immunotherapeutics SA
  • Preclinical
    OT-004
    Leber Congenital Amaurosis (LCA) Odylia Therapeutics Inc
  • Phase 2
    OTL-201
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Kyowa Kirin Co Ltd
  • Phase 1
    OTOV-101
    Deafness Suzhou Otovia Therapeutics Co Ltd
  • Phase 1
    OTS-167
    Metastatic Breast Cancer OncoTherapy Science Inc
  • Phase 1
    OV-329
    Seizures$OVID Ovid Therapeutics Inc.
  • Preclinical
    OX-390
    Acute Opioid Overdosage Orexo AB
  • Phase 2
    OXI-4503
    Refractory Acute Myeloid Leukemia$OTLC Oncotelic Therapeutics, Inc.
  • OXYGEN
    OXYGEN
    no indication AIR LIQUID INDUSTRIAL US LP
  • OZILTUS
    OZILTUS (DENOSUMAB-MOBZ)
    no indication AMNEAL PHARMS LLC
  • Preclinical
    Obesity
    Obesity Metallomix Inc
  • Preclinical
    Oligonucleotide for Charcot-Marie-Tooth Disease Type I A
    Charcot-Marie-Tooth Disease Type I A MaasiRNA
  • Phase 3
    OncoVAX
    OncoVAX
    Colon Cancer Vaccinogen Inc
  • Preclinical
    Oncolipin-IT
    Colorectal Cancer XEME BioPharma Inc
  • Preclinical
    Oncoplex
    Glioblastoma Multiforme (GBM)$PYPD PolyPid Ltd.
  • Phase 1
    Oncoquest
    Oncoquest
    Chronic Lymphocytic Leukemia (CLL) XEME BioPharma Inc
  • Marketed
    Oncotice
    Tice BCG
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$MRK Merck & Co., Inc.
  • Phase 2
    OpRegen
    OpRegen
    Geographic Atrophy F. Hoffmann-La Roche Ltd
  • Phase 2
    Optiquel
    Optiquel
    Non-infectious Uveitis Enzo Biochem Inc
  • Marketed
    Opzelura
    Opzelura (ruxolitinib phosphate)
    Hidradenitis Suppurativa$INCY INCYTE CORP
  • Marketed
    Orabloc
    Orabloc ((articaine hydrochloride + epinephrine bitartrate))
    Local Anesthetic Effect Pierrel SpA
  • Phase 2
    Organ Dysfunction/Mortality
    Unspecified BioAegis Therapeutics Inc
  • Phase 2
    OriCAR-017
    Refractory Multiple Myeloma Oricell Therapeutics (Shanghai) Co Ltd